[ad_1]
Borrowing rates for investors seeking to short Icahn Enterprises. have spiked more than fivefold, to above 25%, since the company and its founder and majority shareholder Carl Icahn agreed to pay $2 million to settle regulatory charges this week.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...